Atlas Trials

A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies

Clinical trial NCT02503033 · UNKNOWN

Trial details

NCT number
NCT02503033
Sponsor
Hutchison Medipharma Limited
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hematologic Malignancies
Start date
2015-11-01
Primary completion
2020-12-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.